Search Results - "Laemmer, Marc"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Failure of antimicrobial therapy to accelerate spontaneous healing of subclinical pulmonary abscesses on a farm with endemic infections caused by Rhodococcus equi by Venner, Monica, Rödiger, Anne, Laemmer, Marc, Giguère, Steeve

    Published in The veterinary journal (1997) (01-06-2012)
    “…Mass antimicrobial treatment of foals with small ultrasonographic pulmonary lesions is common on farms with endemic disease caused by Rhodococcus equi. The…”
    Get full text
    Journal Article
  2. 2

    Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines by Bresgen, Claudia, Lämmer, Marc, Wagner, Bettina, Osterrieder, Nikolaus, Damiani, Armando Mario

    Published in Veterinary microbiology (09-11-2012)
    “…Equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) cause infections of horses worldwide. While both EHV-1 and EHV-4 cause respiratory disease, abortion and…”
    Get full text
    Journal Article
  3. 3

    Clarithromycin is absorbed by an intestinal uptake mechanism that is sensitive to major inhibition by rifampicin: results of a short-term drug interaction study in foals by Peters, Jette, Eggers, Karen, Oswald, Stefan, Block, Wiebke, Lütjohann, Dieter, Lämmer, Marc, Venner, Monica, Siegmund, Werner

    Published in Drug metabolism and disposition (01-03-2012)
    “…Pulmonary penetration of clarithromycin (CLR) in epithelial lining fluid (ELF) and bronchoalveolar lavage cells (BALCs) can be influenced by CYP3A4, by…”
    Get full text
    Journal Article
  4. 4

    Oral Absorption of Clarithromycin Is Nearly Abolished by Chronic Comedication of Rifampicin in Foals by PETERS, Jette, BLOCK, Wiebke, OSWALD, Stefan, FREYER, Johanna, GRUBE, Markus, KROEMER, Heyo K, LAMMER, Marc, LUTJOHANN, Dieter, VENNER, Monica, SIEGMUND, Werner

    Published in Drug metabolism and disposition (01-09-2011)
    “…The delivery of clarithromycin (CRL) to its site of action in bronchial/alveolar epithelial cells (EC), bronchial epithelial lining fluid (ELF), and…”
    Get full text
    Journal Article